A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bittoo Kanwar
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
114 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medizinische Universität Graz
Graz, Austria
- Lkh Innsbruck
Innsbruck, Austria
- Krankenhaus Der Elisabethinen Linz Gmbh
Linz, Austria
- Akh Der Stadt Wien
Vienna, Austria
- Wilhelminenspital Der Stadt Wien
Vienna, Austria
- Sgs - Clinical Pharmacology Unit Antwerpen
Antwerp, Belgium
- Ucl Saint Luc
Brussels, Belgium
- Ulb Erasme
Brussels, Belgium
- Uz Antwerp
Edegem, Belgium
- Chu Sart Tilman
Liège, Belgium
- Heritage Medical Research Clinic
Calgary, Alberta, Canada
- University of Alberta, Division of Gastroenterology
Edmonton, Alberta, Canada
- Downtown Id Clinic
Vancouver, British Columbia, Canada
- Gi Research Institute
Vancouver, British Columbia, Canada
- Gordon & Leslie Diamond Health Care Centre
Vancouver, British Columbia, Canada
- John Buhler Research Centre
Winnipeg, Manitoba, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Ottawa Hospital, Division of Infectious Diseases
Ottawa, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- Toronto Western Hospital
Toronto, Ontario, Canada
- University Hospital Brno
Brno, Czechia
- Melnik Hospital
Mělník, Czechia
- University Hospital Plzen
Pilsen, Czechia
- Institute of Clinic and Experimental Medicine
Prague, Czechia
- Klinmed, S.R.O.
Prague, Czechia
- Association of Physicians for Infection Diseases
Ústí nad Labem, Czechia
- Beaujon Hospital
Clichy, France
- Henri Mondor Hospital
Créteil, France
- Claude Huriez Hospital
Lille, France
- Hotel Dieu Hospital
Lyon, France
- Saint Joseph Hospital
Marseille, France
- Nancy University Hospital Center
Vandœuvre-lès-Nancy, France
- Charite University Medicine
Berlin, Germany
- University Hospital Bonn
Bonn, Germany
- University Hospital Essen
Essen, Germany
- Klinikum Der Johann Wolfgang Goethe-Universität
Frankfurt/M, Germany
- University Hospital Freiburg
Freiburg im Breisgau, Germany
- Ifi - Institut Fuer Interdisziplinaere Medizin - Studien Und Projekte Gmbh
Hamburg, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- University Hospital Heidelberg
Heidelberg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 31 Jan 2013
- Completion
- 30 Sept 2013
- Last update posted
- 28 Jan 2014
- Registered enrollment
- 324
- Registry id
- NCT01225380
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.